GlassScriptPhysician profile
Ceara Drexel
NPI 1710631486
$487.49
in general payments reported to CMS, 2019-2025
14 companies · $284 in 2025
The $284 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $45.90 · 2024: $158 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $441.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $78.75 | 2025 | Neffy, Odactra, Ragwitek |
| Collegium Pharmaceutical, INC. | $65.49 | 2025 | Jornay Pm |
| Verrica Pharmaceuticals INC. | $57.19 | 2024-2025 | Ycanth |
| Merck Sharp & Dohme LLC | $46.53 | 2025 | Gardasil 9, Vaxneuvance, Enflonsia |
| Seqirus USA INC | $42.91 | 2024-2025 | Flucelvax |
| Vertical Pharmaceuticals, LLC | $33.62 | 2025 | Relexxii |
| Ironshore Pharmaceuticals INC. | $28.60 | 2024 | |
| Sanofi Pasteur INC. | $26.40 | 2022 | |
| Abbott Laboratories | $23.11 | 2024 | Id Now Strep A 2 |
| Sobi, INC | $19.50 | 2022 | |
| Corium, LLC | $17.94 | 2025 | Azstarys |
| Cranial Technologies, INC | $17.71 | 2024 | Doc Band |
| Glaxosmithkline, LLC. | $15.57 | 2024 | Bexsero |
| Phadia US INC. | $14.17 | 2024 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ceara Drexel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.